血液透析机/腹膜透析市场规模、份额和成长分析（按类型、产品、最终用途和地区）：产业预测（2024-2031）

2022年全球血液透析机/腹膜透析市场规模将为811.1亿美元，从2023年的863.8亿美元扩大到2031年的1429.7亿美元，并将在预测期内（2024-2031年）增长。成长率为6.5%）。

由于器官捐赠者短缺、急性肾损伤盛行率上升以及器官移植相关风险，全球血液透析机和腹膜透析市场正经历显着成长。此外，大公司的技术进步和创新正在刺激新产品和服务的开发。慢性肾臟病（CKD）通常会导致末期肾功能衰竭（ESRD），是该市场的主要需求驱动因素，因为肾功能下降与糖尿病和高血压等疾病有关。特别是，由于老化、肥胖和不良生活习惯导致糖尿病盛行率不断上升，导致糖尿病肾臟病和肾臟损害，进一步加速了全球对透析治疗的需求。

目录

介绍

• 分析目的
• 定义
• 市场范围

分析方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 监管环境
• 价值链分析
• 供应链分析
• 技术分析
• 专利分析
• 价格分析
• 贸易分析
• 客户和购买标准分析

血液透析机/腹膜透析市场：依类型

• 市场概况
• 血液透析机
  • 传统的
  • 短期透析
  • 夜间血液透析机
• 腹膜透析
  • 连续性携带式腹膜透析（CAPD）
  • 自动腹膜透析（APD）

血液透析机/腹膜透析市场：副产品

• 市场概况
• 装置
  • 机器
  • 透析设备
  • 水处理系统
  • 其他的
• 消耗品
  • 血统
  • 集中
  • 导管
  • 其他的
• 服务

血液透析机/腹膜透析市场：依最终用途

• 市场概况
• 以家庭为基础
• 以医院为基础

血液透析机/腹膜透析市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲 (MEA)
  • 波湾合作理事会(GCC) 国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• 费森尤斯医疗保健股份公司（德国）
• 巴克斯特（美国）
• 达维塔公司（美国）
• 日机装株式会社（日本）
• 贝朗公司（德国）
• 美敦力（美国）
• 旭化成株式会社（日本）
• 泰尔茂株式会社（日本）
• 东丽医疗株式会社（日本）
• 尼普罗株式会社（日本）
• Diaverum AB（瑞典）
• Dialife SA（瑞士）
• Isopure 公司（美国）
• 罗克韦尔医疗公司（美国）
• 贝克顿迪金森公司（美国）
• JMS有限公司（日本）
• 奥美医疗用品有限公司 (中国)
• 大西洋生物医学（美国）
• 血管动力学（美国）
• Amecath (Egypt)
• 库克（美国）
• 医疗元件公司（美国）
• 综合医学（印度）
• 赛莱默（美国）
• Outset Medical, Inc.（美国）

Global Hemodialysis and Peritoneal Dialysis Market size was valued at USD 81.11 billion in 2022 and is poised to grow from USD 86.38 billion in 2023 to USD 142.97 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The global hemodialysis and peritoneal dialysis market is experiencing significant growth, driven by a shortage of organ donors, the rising prevalence of acute kidney injury, and the associated risks of organ transplants. Additionally, technological advancements and innovations from leading market players are fueling the development of new products and services. Chronic kidney disease (CKD), often leading to End-Stage Renal Disease (ESRD), is a major driver of this demand, with kidney function decline linked to conditions like diabetes and hypertension. The growing incidence of diabetes, particularly due to aging, obesity, and poor lifestyle choices, is contributing to diabetic nephropathy and renal damage, further accelerating the demand for dialysis treatments globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemodialysis and Peritoneal Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemodialysis and Peritoneal Dialysis Market Segmental Analysis

Global Hemodialysis and Peritoneal Dialysis Market is segmented on the type, product, end use, and region. By type, Market is segmented into Hemodialysis, and Peritoneal Dialysis. By product, Market is segmented into Device, Consumables, and Service. By end use, Market is segmented into Home-based, and Hospital-based. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Hemodialysis and Peritoneal Dialysis Market

The rising awareness campaigns surrounding kidney diseases and the availability of treatment options are driving early diagnosis and intervention, thereby expanding the patient base for dialysis therapies. Global initiatives such as World Kidney Day have played a key role in raising awareness about kidney health, encouraging regular screenings. This focus on early detection enables timely interventions, which are crucial for effective treatment. As more people undergo screenings and seek care at earlier stages, the demand for dialysis treatments, including hemodialysis and peritoneal dialysis, is growing. These efforts are contributing significantly to the market's expansion by addressing the increasing need for dialysis solutions worldwide.

Restraints in the Global Hemodialysis and Peritoneal Dialysis Market

The high costs associated with hemodialysis treatment, including equipment, consumables, and facility fees, present a significant challenge to the growth of the global Hemodialysis and Peritoneal Dialysis market. In low- and middle-income countries, the financial burden of accessing proper treatment becomes even more pronounced due to the high expense of necessary equipment. Additionally, reimbursement issues and limited insurance coverage exacerbate these challenges, making it difficult for many patients to afford consistent care. These financial constraints limit the accessibility of treatment options and hinder the overall expansion of the market.

Market Trends of the Global Hemodialysis and Peritoneal Dialysis Market

The global Hemodialysis and Peritoneal Dialysis market is experiencing significant growth driven by the rising prevalence of chronic kidney disease (CKD), improved healthcare infrastructure, and expanded access to renal replacement therapies. Emerging markets present substantial growth opportunities, as these regions see a surge in demand for affordable, localized dialysis solutions. Companies can leverage this growth potential by entering developing economies with cost-effective offerings tailored to meet the specific needs of these markets. This trend highlights the vast potential for expansion, as the demand for dialysis treatments continues to rise globally.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Landscape
• Value Chain Analysis
• Supply Chain Analysis
• Technology Analysis
• Patent Analysis
• Pricing Analysis
• Trade Analysis
• Customer & Buying Criteria Analysis

Hemodialysis And Peritoneal Dialysis Market, By Type

• Market Overview
• Hemodialysis
  • Conventional
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis
• Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Hemodialysis And Peritoneal Dialysis Market, By Product

• Market Overview
• Device
  • Machine
  • Dialyzers
  • Water Treatment System
  • Others
• Consumables
  • Bloodlines
  • Concentrates
  • Catheters
  • Others
• Service

Hemodialysis And Peritoneal Dialysis Market, By End Use

• Market Overview
• Home-based
• Hospital-based

Hemodialysis And Peritoneal Dialysis Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Fresenius Medical Care AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Davita Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toray Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diaverum AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dialife SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isopure Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockwell Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JMS Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allmed Medical Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atlantic Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amecath (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medical Components Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polymedicure (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xylem (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Outset Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments